Although single-cell sequencing shows heterogeneous MAGED4 expression across different cell types in tumors, we used OSCC cell lines to evaluate drug-induced MAGED4 expression, as tumor cells are the most abundant component of tumor tissue and the primary target of anti-tumor immunity. The gene discussed is MAGED4; the disease is neoplasm.